BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hahn GD, LeBlanc JF, Golovics PA, Wetwittayakhlang P, Qatomah A, Wang A, Boodaghians L, Liu Chen Kiow J, Al Ali M, Wild G, Afif W, Bitton A, Lakatos PL, Bessissow T. Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study. World J Gastroenterol 2022; 28(33): 4823-4833 [PMID: 36156919 DOI: 10.3748/wjg.v28.i33.4823]
URL: https://www.wjgnet.com/1007-9327/full/v28/i33/4823.htm
Number Citing Articles
1
Walter Fries, Giorgio Basile, Federica Bellone, Giuseppe Costantino, Anna Viola. Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel DiseaseCells 2023; 12(13): 1722 doi: 10.3390/cells12131722
2
Renata Talar-Wojnarowska, Miłosz Caban, Marta Jastrzębska, Małgorzata Woźniak, Aleksandra Strigáč, Ewa Małecka-Wojciesko. Inflammatory Bowel Diseases in the Elderly: A Focus on Disease Characteristics and Biological Therapy PatternsJournal of Clinical Medicine 2024; 13(10): 2767 doi: 10.3390/jcm13102767
3
Deloshaan Subhaharan, Pradeep Kakkadasam Ramaswamy, Laura Willmann, Hadi Moattar, Maneesha Bhullar, Naveed Ishaq, Alexander Dorrington, Dheeraj Shukla, Carolyn McIvor, John Edwards, Waled Mohsen. Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adultsWorld Journal of Gastroenterology 2023; 29(16): 2469-2478 doi: 10.3748/wjg.v29.i16.2469